| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.8M | +224.3% |
| Cost of Revenue | $33.1M | +662.9% |
| Gross Profit | -$26.3M | -1075.3% |
| R&D Expense | $22.0M | +28.9% |
| SG&A Expense | $39.8M | +41.0% |
| Operating Income | -$110.3M | -89.2% |
| Pre-tax Income | -$123.7M | -218.9% |
| Income Tax | $24K | +2671.1% |
| Net Income | -$123.7M | -219.0% |
| EPS (Basic) | -$1.04 | -197.1% |
| EPS (Diluted) | -$1.04 | -197.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $134.3M | -39.5% |
| Accounts Receivable | $274K | -26.4% |
| Inventory | $4.2M | +18.2% |
| Current Assets | $150.2M | -37.7% |
| Total Assets | $181.2M | -29.0% |
| Current Liabilities | $36.2M | +360.9% |
| Total Liabilities | $53.9M | +455.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.4M | -39.0% |
| Capital Expenditures | $3.4M | -26.7% |
| Investing Cash Flow | -$3.4M | +26.7% |
| Financing Cash Flow | $381K | -99.8% |
| Free Cash Flow | -$87.8M | -34.3% |
| Stockholders' Equity |
| $127.3M |
| -48.2% |